Publications

Citation counts and the most current list are on Google Scholar.

Articles 14

2024

PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors

S. Sinha, R. Vegesna, S. Mukherjee, …, I. Grishagin, …, E. Ruppin +15 more S. Sinha, R. Vegesna, S. Mukherjee, A.V. Kammula, S.R. Dhruba, W. Wu, D.L. Kerr, N.U. Nair, M.G. Jones, N. Yosef, O.V. Stroganov, I. Grishagin, K.D. Aldape, C.M. Blakely, P. Jiang, C.J. Thomas, C.H. Benes, T.G. Bivona, A.A. Schäffer, E. Ruppin

Nature Cancer5 (6), 938–952

2022

The Hidden Pandemic of COVID-19-Induced Organizing Pneumonia

E. Bazdyrev, M. Panova, V. Zherebtsova, A. Burdenkova, I. Grishagin, F. Novikov, V. Nebolsin

Pharmaceuticals15 (12), 1574

2022

Mapping of UK Biobank clinical codes: Challenges and possible solutions

O. Stroganov, A. Fedarovich, E. Wong, …, I. Grishagin, …, J. Bryant +6 more O. Stroganov, A. Fedarovich, E. Wong, Y. Skovpen, E. Pakhomova, I. Grishagin, D. Fedarovich, T. Khasanova, D. Merberg, S. Szalma, J. Bryant

PLOS ONE17 (12), e0275816

2022

A Workflow of Integrated Resources to Catalyze Network Pharmacology Driven COVID-19 Research

G. Zahoránszky-Kőhalmi, V.B. Siramshetty, P. Kumar, …, I. Grishagin, …, T.I. Oprea +14 more G. Zahoránszky-Kőhalmi, V.B. Siramshetty, P. Kumar, M. Gurumurthy, B. Grillo, B. Mathew, D. Metaxatos, M. Backus, T. Mierzwa, R. Simon, I. Grishagin, L. Brovold, E.A. Mathé, M.D. Hall, S.G. Michael, A.G. Godfrey, J. Mestres, L.J. Jensen, T.I. Oprea

J. Chem. Inf. Model.62 (3), 718–729

2022

NCATS Inxight Drugs: a comprehensive and curated portal for translational research

V.B. Siramshetty, I. Grishagin, Ð.-T. Nguyễn, …, N.T. Southall +7 more V.B. Siramshetty, I. Grishagin, Ð.-T. Nguyễn, T. Peryea, Y. Skovpen, O. Stroganov, D. Katzel, T. Sheils, A. Jadhav, E.A. Mathé, N.T. Southall

Nucleic Acids Res.50 (D1), D1307–D1316

2021

Lung Fibrosis after COVID-19: Treatment Prospects

E. Bazdyrev, P. Rusina, M. Panova, F. Novikov, I. Grishagin, V. Nebolsin

Pharmaceuticals14 (8), 807

2020

An integrative knowledge graph for rare diseases, derived from the Genetic and Rare Diseases Information Center (GARD)

Q. Zhu, Ð.-T. Nguyễn, I. Grishagin, N. Southall, E. Sid, A. Pariser

J. Biomed. Semant.11, 13

2019

Pathways, Processes, and Candidate Drugs Associated with a Hoxa Cluster-Dependency Model of Leukemia

L. Kettyle, C.E. Lebert-Ghali, I.V. Grishagin, …, A. Thompson +6 more L. Kettyle, C.E. Lebert-Ghali, I.V. Grishagin, G. Dickson, P.G. O'Reilly, D. Simpson, J. Bijl, K. Mills, G. Sauvageau, A. Thompson

Cancers11 (12), 2036

2019

The NCATS BioPlanet – An Integrated Platform for Exploring the Universe of Cellular Signaling Pathways for Toxicology, Systems Biology, and Chemical Genomics

R. Huang, I. Grishagin, Y. Wang, …, C.P. Austin +9 more R. Huang, I. Grishagin, Y. Wang, T. Zhao, J. Greene, J.C. Obenauer, D. Ngan, D.-T. Nguyen, R. Guha, A. Jadhav, N. Southall, A. Simeonov, C.P. Austin

Front. Pharmacol.10, 445

2016

Low-Dose Salinomycin Induces Anti-leukemic Responses in AML and MLL

G. Roulston, C. Burt, L. Kettyle, …, I. Grishagin, …, A. Thompson +7 more G. Roulston, C. Burt, L. Kettyle, K. Matchett, H. Keenan, N. Mulgrew, J. Ramsey, C. Dougan, J. McKiernan, I. Grishagin, K. Mills, A. Thompson

Oncotarget7 (45), 73448–73461

2015

Automatic Cell Counting with ImageJ

I. Grishagin

Anal. Biochem.473, 63–65

2014

In Vivo Anticancer Activity of Rhomboidal Pt(II) Metallacycles

I. Grishagin, J.B. Pollock, S. Kushal, T.R. Cook, P.J. Stang, B.Z. Olenyuk

PNAS111 (52), 18448–18453

2014

In Vivo Modulation of Hypoxia-Inducible Signaling by Topographical Helix Mimetics

B.B. Lao*, I. Grishagin*, H. Mesallati, T. Brewer, B.Z. Olenyuk, P.S. Arora

* Authors contributed equally.

PNAS111 (21), 7531–7536

2007

Polyisobutylene-block-Poly(methacrylic acid) Diblock Copolymers: Self-Assembly in Aqueous Media

M. Burkhardt, N. Martinez-Castro, S. Tea, …, I. Grishagin, …, A.H.E. Müller +6 more M. Burkhardt, N. Martinez-Castro, S. Tea, M. Drechsler, I. Babin, I. Grishagin, R. Schweins, D.V. Pergushov, M. Gradzielski, A.B. Zezin, A.H.E. Müller

Langmuir23 (26), 12864–12874

Conference abstracts 8

2017

High-throughput screen identification of albendazole as a novel repurposed drug in acute myeloid leukaemia

K.B. Matchett, I.V. Grishagin, L.M. Kettyle, C. Dowling, T.N. Chonghaile, K.I. Mills, A. Thompson

Blood130 (Suppl. 1), 5062

2016

Mebendazole: A Candidate FDA Approved Drug for Repurposing in Leukaemia

K.B. Matchett, I. Grishagin, L.M. Kettyle, G. Gavory, T. Harrison, K.I. Mills, A. Thompson

Br. J. Haematol.173 (Suppl. S1), 9

2016

Conditional Deletion of the HOXA Cluster in MLL-AF9 is Incompatible with Leukemia Maintenance

L.M. Kettyle, C. Lebert-Ghali, I. Grishagin, …, A. Thompson +5 more L.M. Kettyle, C. Lebert-Ghali, I. Grishagin, G.J. Dickson, J.J. Bijl, M.F. McMullin, T.R. Lappin, K.I. Mills, A. Thompson

Haematologica101 (S1), 38

2016

Conditional Deletion of the Hoxa Cluster in MLL-AF9 is Incompatible with Leukemia Maintenance

L.M. Kettyle, I. Grishagin, G.J. Dickson, C. Lebert-Ghali, J.J. Bijl, K.I. Mills, A. Thompson

Br. J. Haematol.173 (Suppl. S1), 121

2015

Conditional Deletion of the Hoxa Cluster in MLL-AF9 is Incompatible with Leukemia Maintenance

L.M. Kettyle, I. Grishagin, G.J. Dickson, C. Lebert-Ghali, J.J. Bijl, K.I. Mills, A. Thompson

Blood126 (23), 3630

2014

Novel Selective HIF1 Alpha Inhibitor: Well Tolerated with Excellent Efficacy in Renal Cell Cancer Xenograft Studies

R. Dubey, I. Grishagin, U. Nagavarapu, C. Balan, S. Gupta, B.Z. Olenyuk

Cancer Res.74 (19 Suppl.), 1014

2012

OOPs: Novel HIF-1α Mimics

I. Grishagin, B.Z. Olenyuk, B. Bullock, P.S. Arora

Cancer Res.72 (8 Suppl.), 283

2006

Interpolyelectrolyte complexes based on micelles of ionic amphiphilic diblock copolymers

D.V. Pergushov, M. Burkhardt, I.V. Grishagin, I.A. Babin, E.V. Remizova, et al.

Abstracts of Papers of the American Chemical Society231, 317-COLL

Patents 2

2016

Control of Hypoxia-Inducible Gene Expression with Oligooxopiperazine Nonpeptidic Helix Mimetics

P.S. Arora, B.Z. Olenyuk, B. Bullock, I. Grishagin

US Patent 9,255,086 B2

2013

Control of Hypoxia-Inducible Gene Expression with Oligooxopiperazine Nonpeptidic Helix Mimetics

P.S. Arora, B.Z. Olenyuk, B. Bullock, I. Grishagin

International Patent WO 2013/123511 A1

Dissertation 1

2014

Small Molecule Modulators of HIF1α Signaling

I.V. Grishagin

PhD dissertation, University of Southern California